Amundi Asset Management US’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2.08M Buy
41,168
+40,268
+4,474% +$2.24M ﹤0.01% 1181
2020
Q4
$57K Hold
900
﹤0.01% 1442
2020
Q3
$60K Buy
+900
New +$49.1K ﹤0.01% 1439

Other funds holding SILK

Amundi Asset Management US's SILK Position: Q1 2021 in Review

Amundi Asset Management US increased its Silk Road Medical, Inc. Common Stock (SILK) stake by 4,474% in Q1 2021, buying an estimated $2.24M and bringing the position to 41,168 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

Amundi Asset Management US first reported a position in SILK in Q3 2020 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold SILK as of Q1 2021.

  • Amundi Asset Management US held 41,168 shares of Silk Road Medical, Inc. Common Stock worth $2.08M as of Q1 2021.
  • Amundi Asset Management US bought 40,268 Silk Road Medical, Inc. Common Stock shares in Q1 2021, an estimated $2.24M.
  • Silk Road Medical, Inc. Common Stock made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1181 holding.
  • Amundi Asset Management US first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.